{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:58:33Z","timestamp":1792249113247,"version":"4.4.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873292"],"award-info":[{"award-number":["81873292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7212190"],"award-info":[{"award-number":["7212190"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005893","name":"China Academy of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["CI2021A01506"],"award-info":[{"award-number":["CI2021A01506"]}],"id":[{"id":"10.13039\/501100005893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10753-024-02002-9","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T09:02:31Z","timestamp":1711098151000},"page":"1685-1698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of H3K27me3-Mediated Th17 Differentiation in Ankylosing Spondylitis"],"prefix":"10.1007","volume":"47","author":[{"given":"Yuening","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"issue":"9570","key":"2002_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun, J., and J. Sieper. 2007. Ankylosing spondylitis. Lancet 369 (9570): 1379\u20131390.","journal-title":"Lancet"},{"issue":"2","key":"2002_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrrheum.2009.258","volume":"6","author":"WP Maksymowych","year":"2010","unstructured":"Maksymowych, W.P. 2010. Disease modification in ankylosing spondylitis. Nature Reviews Rheumatology 6 (2): 75\u201381.","journal-title":"Nature Reviews Rheumatology"},{"issue":"12","key":"2002_CR3","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","volume":"80","author":"V Navarro-Comp\u00e1n","year":"2021","unstructured":"Navarro-Comp\u00e1n, V., A. Sepriano, B. El-Zorkany, and D. van der Heijde. 2021. Axial spondyloarthritis. Annals of the Rheumatic Diseases 80 (12): 1511\u20131521.","journal-title":"Annals of the rheumatic diseases"},{"issue":"9","key":"2002_CR4","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.1002\/jcp.30313","volume":"236","author":"L Liu","year":"2021","unstructured":"Liu, L., Y. Yuan, S. Zhang, J. Xu, and J. Zou. 2021. Osteoimmunological insights into the pathogenesis of ankylosing spondylitis. Journal of Cellular Physiology 236 (9): 6090\u20136100.","journal-title":"Journal of cellular physiology"},{"issue":"10","key":"2002_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec, P., and J.K. Kolls. 2012. Targeting IL-17 and TH17 cells in chronic inflammation. Nature Reviews Drug Discovery 11 (10): 763\u2013776.","journal-title":"Nature reviews drug discovery"},{"issue":"10","key":"2002_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tips.2014.07.006","volume":"35","author":"J Yang","year":"2014","unstructured":"Yang, J., M.S. Sundrud, J. Skepner, and T. Yamagata. 2014. Targeting Th17 cells in autoimmune diseases. Trends in Pharmacological Sciences 35 (10): 493\u2013500.","journal-title":"Trends in pharmacological sciences"},{"issue":"3","key":"2002_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/art.39464","volume":"68","author":"E Gracey","year":"2016","unstructured":"Gracey, E., Y. Yao, B. Green, Z. Qaiyum, Y. Baglaenko, A. Lin, A. Anton, R. Ayearst, P. Yip, and R.D. Inman. 2016. Sexual dimorphism in the Th17 signature of ankylosing spondylitis. Arthritis & Rheumatology (Hoboken, NJ) 68 (3): 679\u2013689.","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"1","key":"2002_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13075-019-1948-1","volume":"21","author":"C Klasen","year":"2019","unstructured":"Klasen, C., A. Meyer, P.S. Wittekind, I. Waqu\u00e9, S. Nabhani, and D.M. Kofler. 2019. Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis. Arthritis Research & Therapy 21 (1): 159.","journal-title":"Arthritis research & therapy"},{"issue":"6","key":"2002_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.berh.2018.07.010","volume":"31","author":"JSH Gaston","year":"2017","unstructured":"Gaston, J.S.H., and D.R. Jadon. 2017. Th17 cell responses in spondyloarthritis. Best practice & research Clinical Rheumatology 31 (6): 777\u2013796.","journal-title":"Best practice & research Clinical rheumatology"},{"issue":"3","key":"2002_CR10","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/annrheumdis-2016-210175","volume":"76","author":"L Chen","year":"2017","unstructured":"Chen, L., M.H. Al-Mossawi, A. Ridley, T. Sekine, A. Hammitzsch, J. de Wit, D. Simone, H. Shi, F. Penkava, M. Kurowska-Stolarska, et al. 2017. miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis. Annals of the Rheumatic Diseases 76 (3): 620\u2013625.","journal-title":"Annals of the rheumatic diseases"},{"key":"2002_CR11","doi-asserted-by":"publisher","first-page":"608900","DOI":"10.3389\/fimmu.2020.608900","volume":"11","author":"J McGinty","year":"2020","unstructured":"McGinty, J., N. Brittain, and T.J. Kenna. 2020. Looking beyond Th17 cells: A role for Tr1 cells in ankylosing spondylitis? Frontiers in Immunology 11: 608900.","journal-title":"Frontiers in immunology"},{"issue":"14","key":"2002_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s40265-018-0971-x","volume":"78","author":"SJ Pedersen","year":"2018","unstructured":"Pedersen, S.J., and W.P. Maksymowych. 2018. Beyond the TNF-\u03b1 inhibitors: New and emerging targeted therapies for patients with axial spondyloarthritis and their relation to pathophysiology. Drugs 78 (14): 1397\u20131418.","journal-title":"Drugs"},{"issue":"26","key":"2002_CR13","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten, D., J. Sieper, J. Braun, X. Baraliakos, M. Dougados, P. Emery, A. Deodhar, B. Porter, R. Martin, M. Andersson, et al. 2015. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. The New England Journal of Medicine 373 (26): 2534\u20132548.","journal-title":"The New England journal of medicine"},{"issue":"3","key":"2002_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/icb.2014.115","volume":"93","author":"F Antignano","year":"2015","unstructured":"Antignano, F., and C. Zaph. 2015. Regulation of CD4 T-cell differentiation and inflammation by repressive histone methylation. Immunology and Cell Biology 93 (3): 245\u2013252.","journal-title":"Immunology and cell biology"},{"issue":"7","key":"2002_CR15","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.3390\/ijms24076463","volume":"24","author":"S Del Vescovo","year":"2023","unstructured":"Del Vescovo, S., V. Venerito, C. Iannone, and G. Lopalco. 2023. Uncovering the underworld of axial spondyloarthritis. International Journal of Molecular Sciences 24 (7): 6463.","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"2002_CR16","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/emboj.2011.103","volume":"30","author":"F Roudier","year":"2011","unstructured":"Roudier, F., I. Ahmed, C. Berard, A. Sarazin, T. Mary-Huard, S. Cortijo, D. Bouyer, E. Caillieux, E. Duvernois-Berthet, L. Al-Shikhley, et al. 2011. Integrative epigenomic mapping defines four main chromatin states in arabidopsis. The EMBO Journal 30 (10): 1928\u20131938.","journal-title":"The EMBO journal"},{"issue":"10","key":"2002_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/abbs\/gmu078","volume":"46","author":"H Tang","year":"2014","unstructured":"Tang, H., S. An, H. Zhen, and F. Chen. 2014. Characterization of combinatorial histone modifications on lineage-affiliated genes during hematopoietic stem cell myeloid commitment. Acta Biochimica et Biophysica Sinica 46 (10): 894\u2013901.","journal-title":"Acta biochimica et biophysica Sinica"},{"issue":"1","key":"2002_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/abbs\/gmr100","volume":"44","author":"X Zhang","year":"2012","unstructured":"Zhang, X., H. Wen, and X. Shi. 2012. Lysine methylation: Beyond histones. Acta Biochimica et Biophysica Sinica 44 (1): 14\u201327.","journal-title":"Acta biochimica et biophysica Sinica"},{"issue":"7163","key":"2002_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nature06145","volume":"449","author":"K Agger","year":"2007","unstructured":"Agger, K., P.A. Cloos, J. Christensen, D. Pasini, S. Rose, J. Rappsilber, I. Issaeva, E. Canaani, A.E. Salcini, and K. Helin. 2007. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449 (7163): 731\u2013734.","journal-title":"Nature"},{"issue":"1","key":"2002_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cell.2017.08.002","volume":"171","author":"B Schuettengruber","year":"2017","unstructured":"Schuettengruber, B., H.M. Bourbon, L. Di Croce, and G. Cavalli. 2017. Genome regulation by polycomb and trithorax: 70 years and counting. Cell 171 (1): 34\u201357.","journal-title":"Cell"},{"key":"2002_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1101\/sqb.2010.75.020","volume":"75","author":"MR Hubner","year":"2010","unstructured":"Hubner, M.R., and D.L. Spector. 2010. Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation. Cold Spring Harbor Symposia on Quantitative Biology 75: 43\u201349.","journal-title":"Cold Spring Harbor symposia on quantitative biology"},{"issue":"1","key":"2002_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan, R., W. Du, and W. Guo. 2020. EZH2: A novel target for cancer treatment. Journal of Hematology & Oncology 13 (1): 104.","journal-title":"Journal of hematology & oncology"},{"issue":"1","key":"2002_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-020-0818-7","volume":"12","author":"F Hoffmann","year":"2020","unstructured":"Hoffmann, F., D. Niebel, P. Aymans, S. Ferring-Schmitt, D. Dietrich, and J. Landsberg. 2020. H3K27me3 and EZH2 expression in melanoma: Relevance for melanoma progression and response to immune checkpoint blockade. Clinical Epigenetics 12 (1): 24.","journal-title":"Clinical epigenetics"},{"issue":"6","key":"2002_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/jmcb\/mjv022","volume":"7","author":"Z Liu","year":"2015","unstructured":"Liu, Z., W. Cao, L. Xu, X. Chen, Y. Zhan, Q. Yang, S. Liu, P. Chen, Y. Jiang, X. Sun, et al. 2015. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation. Journal of Molecular Cell Biology 7 (6): 505\u2013516.","journal-title":"Journal of molecular cell biology"},{"key":"2002_CR25","doi-asserted-by":"publisher","first-page":"10643","DOI":"10.1038\/srep10643","volume":"5","author":"XP Yang","year":"2015","unstructured":"Yang, X.P., K. Jiang, K. Hirahara, G. Vahedi, B. Afzali, G. Sciume, M. Bonelli, H.W. Sun, D. Jankovic, Y. Kanno, et al. 2015. EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion. Scientific Reports 5: 10643.","journal-title":"Scientific reports"},{"issue":"11","key":"2002_CR26","doi-asserted-by":"publisher","first-page":"e0188391","DOI":"10.1371\/journal.pone.0188391","volume":"12","author":"U Guendisch","year":"2017","unstructured":"Guendisch, U., J. Weiss, F. Ecoeur, J.C. Riker, K. Kaupmann, J. Kallen, S. Hintermann, D. Orain, J. Dawson, A. Billich, et al. 2017. Pharmacological inhibition of RORgammat suppresses the Th17 pathway and alleviates arthritis in vivo. PLoS ONE 12 (11): e0188391.","journal-title":"PLoS ONE"},{"issue":"6","key":"2002_CR27","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/eji.200939540","volume":"39","author":"D Unutmaz","year":"2009","unstructured":"Unutmaz, D. 2009. RORC2: The master of human Th17 cell programming. European Journal of Immunology 39 (6): 1452\u20131455.","journal-title":"European journal of immunology"},{"issue":"7344","key":"2002_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature09978","volume":"472","author":"JR Huh","year":"2011","unstructured":"Huh, J.R., M.W. Leung, P. Huang, D.A. Ryan, M.R. Krout, R.R. Malapaka, J. Chow, N. Manel, M. Ciofani, S.V. Kim, et al. 2011. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 472 (7344): 486\u2013490.","journal-title":"Nature"},{"issue":"1","key":"2002_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13046-022-02289-2","volume":"41","author":"L Xia","year":"2022","unstructured":"Xia, L., E. Tian, M. Yu, C. Liu, L. Shen, Y. Huang, Z. Wu, J. Tian, K. Yu, Y. Wang, et al. 2022. ROR\u03b3t agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers. Journal of Experimental & Clinical Cancer Research\u202f: CR 41 (1): 155.","journal-title":"Journal of experimental & clinical cancer research : CR"},{"issue":"1","key":"2002_CR30","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1038\/s41467-019-12680-x","volume":"10","author":"H Yahia-Cherbal","year":"2019","unstructured":"Yahia-Cherbal, H., M. Rybczynska, D. Lovecchio, T. Stephen, C. Lescale, K. Placek, J. Larghero, L. Rogge, and E. Bianchi. 2019. NFAT primes the human RORC locus for ROR\u03b3t expression in CD4+ T cells. Nature Communications 10 (1): 4698.","journal-title":"Nature communications"},{"issue":"5955","key":"2002_CR31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1126\/science.1172702","volume":"326","author":"A Chaudhry","year":"2009","unstructured":"Chaudhry, A., D. Rudra, P. Treuting, R.M. Samstein, Y. Liang, A. Kas, and A.Y. Rudensky. 2009. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326 (5955): 986\u2013991.","journal-title":"Science"},{"key":"2002_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.biocel.2015.07.006","volume":"67","author":"JS Burchfield","year":"2015","unstructured":"Burchfield, J.S., Q. Li, H.Y. Wang, and R.F. Wang. 2015. JMJD3 as an epigenetic regulator in development and disease. The International Journal of Biochemistry & Cell Biology 67: 148\u2013157.","journal-title":"The international journal of biochemistry & cell biology"},{"issue":"11","key":"2002_CR33","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.4049\/jimmunol.1101058","volume":"187","author":"CJ Cohen","year":"2011","unstructured":"Cohen, C.J., S.Q. Crome, K.G. MacDonald, E.L. Dai, D.L. Mager, and M.K. Levings. 2011. Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. Journal of Immunology 187 (11): 5615\u20135626.","journal-title":"Journal of immunology"},{"issue":"3","key":"2002_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00109-014-1122-9","volume":"92","author":"UK Hanisch","year":"2014","unstructured":"Hanisch, U.K. 2014. Linking STAT and TLR signaling in microglia: A new role for the histone demethylase Jmjd3. Journal of Molecular Medicine 92 (3): 197\u2013200.","journal-title":"Journal of molecular medicine"},{"issue":"8","key":"2002_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","volume":"14","author":"LS Taams","year":"2018","unstructured":"Taams, L.S., K.J.A. Steel, U. Srenathan, L.A. Burns, and B.W. Kirkham. 2018. IL-17 in the immunopathogenesis of spondyloarthritis. Nature Reviews Rheumatology 14 (8): 453\u2013466.","journal-title":"Nature reviews rheumatology"},{"issue":"7","key":"2002_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","volume":"10","author":"DJ Cua","year":"2010","unstructured":"Cua, D.J., and C.M. Tato. 2010. Innate IL-17-producing cells: The sentinels of the immune system. Nature Reviews Immunology 10 (7): 479\u2013489.","journal-title":"Nature reviews immunology"},{"issue":"5","key":"2002_CR37","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.4049\/jimmunol.0801967","volume":"182","author":"S Zrioual","year":"2009","unstructured":"Zrioual, S., R. Ecochard, A. Tournadre, V. Lenief, M.A. Cazalis, and P. Miossec. 2009. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. Journal of Immunology 182 (5): 3112\u20133120.","journal-title":"Journal of immunology"},{"issue":"7","key":"2002_CR38","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ni.3748","volume":"18","author":"J Geng","year":"2017","unstructured":"Geng, J., S. Yu, H. Zhao, X. Sun, X. Li, P. Wang, X. Xiong, L. Hong, C. Xie, J. Gao, et al. 2017. The transcriptional coactivator TAZ regulates reciprocal differentiation of T(H)17 cells and T(reg) cells. Nature Immunology 18 (7): 800\u2013812.","journal-title":"Nature immunology"},{"issue":"6","key":"2002_CR39","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov, I.I., B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, J.J. Lafaille, D.J. Cua, and D.R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (6): 1121\u20131133.","journal-title":"Cell"},{"issue":"7829","key":"2002_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","volume":"586","author":"M Zhang","year":"2020","unstructured":"Zhang, M., L. Zhou, Y. Xu, M. Yang, Y. Xu, G.P. Komaniecki, T. Kosciuk, X. Chen, X. Lu, X. Zou, et al. 2020. A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis. Nature 586 (7829): 434\u2013439.","journal-title":"Nature"},{"issue":"1","key":"2002_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cell.2019.11.026","volume":"180","author":"JY Lee","year":"2020","unstructured":"Lee, J.Y., J.A. Hall, L. Kroehling, L. Wu, T. Najar, H.H. Nguyen, W.Y. Lin, S.T. Yeung, H.M. Silva, D. Li, et al. 2020. Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease. Cell 180 (1): 79-91.e16.","journal-title":"Cell"},{"issue":"5","key":"2002_CR42","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.berh.2010.05.009","volume":"24","author":"K de Vlam","year":"2010","unstructured":"de Vlam, K. 2010. Soluble and tissue biomarkers in ankylosing spondylitis. Best Practice & Research Clinical Rheumatology 24 (5): 671\u2013682.","journal-title":"Best practice & research Clinical rheumatology"},{"issue":"1","key":"2002_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7150\/thno.46360","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., C. Xiang, F. Zhong, Y. Zhang, L. Wang, Y. Zhao, J. Wang, C. Ding, L. Jin, F. He, et al. 2021. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics 11 (1): 361\u2013378.","journal-title":"Theranostics"},{"key":"2002_CR44","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1038\/ncomms6780","volume":"5","author":"Q Li","year":"2014","unstructured":"Li, Q., J. Zou, M. Wang, X. Ding, I. Chepelev, X. Zhou, W. Zhao, G. Wei, J. Cui, K. Zhao, et al. 2014. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation. Nature Communications 5: 5780.","journal-title":"Nature communications"},{"issue":"11","key":"2002_CR45","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.1073\/pnas.1919893117","volume":"117","author":"AP Cribbs","year":"2020","unstructured":"Cribbs, A.P., S. Terlecki-Zaniewicz, M. Philpott, J. Baardman, D. Ahern, M. Lindow, S. Obad, H. Oerum, B. Sampey, P.K. Mander, et al. 2020. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism. Proceedings of the National Academy of Sciences of the United States of America 117 (11): 6056\u20136066.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"2002_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.molimm.2019.12.019","volume":"118","author":"Q Chen","year":"2020","unstructured":"Chen, Q., X. Duan, M. Xu, H. Fan, Y. Dong, H. Wu, M. Zhang, Y. Liu, Z. Nan, S. Deng, et al. 2020. BMSC-EVs regulate Th17 cell differentiation in UC via H3K27me3. Molecular Immunology 118: 191\u2013200.","journal-title":"Molecular immunology"},{"issue":"3","key":"2002_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12026-014-8612-2","volume":"61","author":"X Liu","year":"2015","unstructured":"Liu, X., S. Ren, X. Qu, C. Ge, K. Cheng, and R.C. Zhao. 2015. Mesenchymal stem cells inhibit Th17 cells differentiation via IFN-\u03b3-mediated SOCS3 activation. Immunologic Research 61 (3): 219\u2013229.","journal-title":"Immunologic research"},{"key":"2002_CR48","doi-asserted-by":"publisher","first-page":"109693","DOI":"10.1016\/j.intimp.2023.109693","volume":"115","author":"Y Lu","year":"2023","unstructured":"Lu, Y., Q. Ma, L. Yu, H. Huang, X. Liu, P. Chen, H. Ran, and W. Liu. 2023. JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17\/Treg cells via regulating the JAK2\/STAT3-AKT\/mTOR signaling pathway. International Immunopharmacology 115: 109693.","journal-title":"International immunopharmacology"},{"issue":"6","key":"2002_CR49","doi-asserted-by":"publisher","first-page":"G774","DOI":"10.1152\/ajpgi.00053.2019","volume":"316","author":"L He","year":"2019","unstructured":"He, L., J. Du, Y. Chen, C. Liu, M. Zhou, S. Adhikari, D.T. Rubin, J. Pekow, and Y.C. Li. 2019. Renin-angiotensin system promotes colonic inflammation by inducing T(H)17 activation via JAK2\/STAT pathway. American Journal of Physiology Gastrointestinal and Liver Physiology 316 (6): G774\u2013G784.","journal-title":"American journal of physiology gastrointestinal and liver physiology"},{"issue":"1","key":"2002_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13075-017-1249-5","volume":"19","author":"SP Raychaudhuri","year":"2017","unstructured":"Raychaudhuri, S.P., and S.K. Raychaudhuri. 2017. Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Research & Therapy 19 (1): 51.","journal-title":"Arthritis research & therapy"},{"issue":"7","key":"2002_CR51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","volume":"11","author":"E Lubberts","year":"2015","unstructured":"Lubberts, E. 2015. The IL-23-IL-17 axis in inflammatory arthritis. Nature Reviews Rheumatology 11 (7): 415\u2013429.","journal-title":"Nature reviews rheumatology"},{"issue":"2","key":"2002_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/1744666X.2019.1561281","volume":"15","author":"S Dubash","year":"2019","unstructured":"Dubash, S., C. Bridgewood, D. McGonagle, and H. Marzo-Ortega. 2019. The advent of IL-17A blockade in ankylosing spondylitis: Secukinumab, ixekizumab and beyond. Expert Review of Clinical Immunology 15 (2): 123\u2013134.","journal-title":"Expert review of clinical immunology"},{"issue":"1","key":"2002_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41556-021-00795-7","volume":"24","author":"P Guo","year":"2022","unstructured":"Guo, P., Y. Liu, F. Geng, A.W. Daman, X. Liu, L. Zhong, A. Ravishankar, R. Lis, J.G. Barcia Dur\u00e1n, T. Itkin, et al. 2022. Histone variant H3.3 maintains adult haematopoietic stem cell homeostasis by enforcing chromatin adaptability. Nature Cell Biology 24 (1): 99\u2013111.","journal-title":"Nature cell biology"},{"issue":"1","key":"2002_CR54","doi-asserted-by":"publisher","first-page":"5596","DOI":"10.1038\/s41467-020-19360-1","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang, Y., P. Deng, Y. Liu, Y. Wu, Y. Chen, Y. Guo, S. Zhang, X. Zheng, L. Zhou, W. Liu, et al. 2020. Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations. Nature Communications 11 (1): 5596.","journal-title":"Nature communications"},{"issue":"8","key":"2002_CR55","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/neuonc\/noab036","volume":"23","author":"F Nassiri","year":"2021","unstructured":"Nassiri, F., J.Z. Wang, O. Singh, S. Karimi, T. Dalcourt, N. Ijad, N. Pirouzmand, H.K. Ng, A. Saladino, B. Pollo, et al. 2021. Loss of H3K27me3 in meningiomas. Neuro-Oncology 23 (8): 1282\u20131291.","journal-title":"Neuro-oncology"},{"issue":"8","key":"2002_CR56","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/neuonc\/noaa303","volume":"23","author":"F Behling","year":"2021","unstructured":"Behling, F., C. Fodi, I. Gepfner-Tuma, K. Kaltenbach, M. Renovanz, F. Paulsen, M. Skardelly, J. Honegger, M. Tatagiba, J. Schittenhelm, et al. 2021. H3K27me3 loss indicates an increased risk of recurrence in the T\u00fcbingen meningioma cohort. Neuro-Oncology 23 (8): 1273\u20131281.","journal-title":"Neuro-oncology"},{"issue":"1","key":"2002_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13148-022-01305-8","volume":"14","author":"J Abu-Hanna","year":"2022","unstructured":"Abu-Hanna, J., J.A. Patel, E. Anastasakis, R. Cohen, L.H. Clapp, M. Loizidou, and M.M.R. Eddama. 2022. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: A review of the literature. Clinical Epigenetics 14 (1): 98.","journal-title":"Clinical epigenetics"},{"issue":"12","key":"2002_CR58","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s13238-019-0653-9","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang, X., L. Liu, X. Yuan, Y. Wei, and X. Wei. 2019. JMJD3 in the regulation of human diseases. Protein & Cell 10 (12): 864\u2013882.","journal-title":"Protein & cell"},{"issue":"1","key":"2002_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41368-022-00190-4","volume":"14","author":"Y Jin","year":"2022","unstructured":"Jin, Y., Z. Liu, Z. Li, H. Li, C. Zhu, R. Li, T. Zhou, and B. Fang. 2022. Histone demethylase JMJD3 downregulation protects against aberrant force-induced osteoarthritis through epigenetic control of NR4A1. International Journal of Oral Science 14 (1): 34.","journal-title":"International journal of oral science"},{"issue":"6606","key":"2002_CR60","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1126\/science.abm9735","volume":"377","author":"K Nakka","year":"2022","unstructured":"Nakka, K., S. Hachmer, Z. Mokhtari, R. Kovac, H. Bandukwala, C. Bernard, Y. Li, G. Xie, C. Liu, M. Fallahi, et al. 2022. JMJD3 activated hyaluronan synthesis drives muscle regeneration in an inflammatory environment. Science 377 (6606): 666\u2013669.","journal-title":"Science"},{"issue":"4","key":"2002_CR61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13238-018-0581-0","volume":"10","author":"D Sun","year":"2019","unstructured":"Sun, D., X. Cao, and C. Wang. 2019. Polycomb chromobox Cbx2 enhances antiviral innate immunity by promoting Jmjd3-mediated demethylation of H3K27 at the Ifnb promoter. Protein & Cell 10 (4): 285\u2013294.","journal-title":"Protein & cell"},{"issue":"6","key":"2002_CR62","doi-asserted-by":"publisher","first-page":"e20201839","DOI":"10.1084\/jem.20201839","volume":"218","author":"FM Davis","year":"2021","unstructured":"Davis, F.M., L.C. Tsoi, W.J. Melvin, A. denDekker, R. Wasikowski, A.D. Joshi, S. Wolf, A.T. Obi, A.C. Billi, X. Xing, et al. 2021. Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms. The Journal of Experimental Medicine 218 (6): e20201839.","journal-title":"The Journal of Experimental Medicine"},{"key":"2002_CR63","doi-asserted-by":"publisher","first-page":"109000","DOI":"10.1016\/j.intimp.2022.109000","volume":"110","author":"XY Leng","year":"2022","unstructured":"Leng, X.Y., J. Yang, H. Fan, Q.Y. Chen, B.J. Cheng, H.X. He, F. Gao, F. Zhu, T. Yu, and Y.J. Liu. 2022. JMJD3\/H3K27me3 epigenetic modification regulates Th17\/Treg cell differentiation in ulcerative colitis. International Immunopharmacology 110: 109000.","journal-title":"International immunopharmacology"},{"issue":"7","key":"2002_CR64","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/art.34423","volume":"64","author":"M Ruutu","year":"2012","unstructured":"Ruutu, M., G. Thomas, R. Steck, M.A. Degli-Esposti, M.S. Zinkernagel, K. Alexander, J. Velasco, G. Strutton, A. Tran, H. Benham, et al. 2012. \u03b2-glucan triggers spondylarthritis and Crohn\u2019s disease-like ileitis in SKG mice. Arthritis and Rheumatism 64 (7): 2211\u20132222.","journal-title":"Arthritis and rheumatism"},{"issue":"6637","key":"2002_CR65","doi-asserted-by":"publisher","first-page":"eabg2482","DOI":"10.1126\/science.abg2482","volume":"379","author":"Y Zhai","year":"2023","unstructured":"Zhai, Y., L. Chen, Q. Zhao, Z.H. Zheng, Z.N. Chen, H. Bian, X. Yang, H.Y. Lu, P. Lin, X. Chen, et al. 2023. Cysteine carboxyethylation generates neoantigens to induce HLA-restricted autoimmunity. Science 379 (6637): eabg2482.","journal-title":"Science"},{"key":"2002_CR66","doi-asserted-by":"publisher","first-page":"622306","DOI":"10.3389\/fimmu.2021.622306","volume":"12","author":"UC Kucuksezer","year":"2021","unstructured":"Kucuksezer, U.C., E. Aktas Cetin, F. Esen, I. Tahrali, N. Akdeniz, M.Y. Gelmez, and G. Deniz. 2021. The role of natural killer cells in autoimmune diseases. Frontiers in Immunology 12: 622306.","journal-title":"Frontiers in immunology"},{"issue":"3","key":"2002_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00109-013-1090-5","volume":"92","author":"P Przanowski","year":"2014","unstructured":"Przanowski, P., M. Dabrowski, A. Ellert-Miklaszewska, M. Kloss, J. Mieczkowski, B. Kaza, A. Ronowicz, F. Hu, A. Piotrowski, H. Kettenmann, et al. 2014. The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. Journal of Molecular Medicine 92 (3): 239\u2013254.","journal-title":"Journal of molecular medicine"},{"issue":"3","key":"2002_CR68","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4143\/crt.2014.46.3.209","volume":"46","author":"H Yamaguchi","year":"2014","unstructured":"Yamaguchi, H., and M.C. Hung. 2014. Regulation and role of EZH2 in cancer. Cancer Research and Treatment 46 (3): 209\u2013222.","journal-title":"Cancer research and treatment"},{"issue":"1","key":"2002_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/leu.2013.288","volume":"28","author":"K Lund","year":"2014","unstructured":"Lund, K., P.D. Adams, and M. Copland. 2014. EZH2 in normal and malignant hematopoiesis. Leukemia 28 (1): 44\u201349.","journal-title":"Leukemia"},{"issue":"5","key":"2002_CR70","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1182\/blood-2013-12-544106","volume":"124","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., S. Kinkel, J. Maksimovic, E. Bandala-Sanchez, M.C. Tanzer, G. Naselli, J.G. Zhang, Y. Zhan, A.M. Lew, J. Silke, et al. 2014. The polycomb repressive complex 2 governs life and death of peripheral T cells. Blood 124 (5): 737\u2013749.","journal-title":"Blood"},{"issue":"1","key":"2002_CR71","doi-asserted-by":"publisher","first-page":"16583","DOI":"10.1038\/s41598-022-21005-w","volume":"12","author":"K Fan","year":"2022","unstructured":"Fan, K., C.L. Zhang, B.H. Zhang, M.Q. Gao, and Y.C. Sun. 2022. Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration. Scientific Reports 12 (1): 16583.","journal-title":"Scientific reports"},{"issue":"9","key":"2002_CR72","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/art.39720","volume":"68","author":"P Coit","year":"2016","unstructured":"Coit, P., M.G. Dozmorov, J.T. Merrill, W.J. McCune, K. Maksimowicz-McKinnon, J.D. Wren, and A.H. Sawalha. 2016. Epigenetic reprogramming in naive CD4+ T cells favoring T cell activation and non-Th1 effector T cell immune response as an early event in lupus flares. Arthritis & Rheumatology (Hoboken, NJ) 68 (9): 2200\u20132209.","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"2","key":"2002_CR73","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/gutjnl-2018-317645","volume":"69","author":"M Maeda","year":"2020","unstructured":"Maeda, M., H. Takeshima, N. Iida, N. Hattori, S. Yamashita, H. Moro, Y. Yasukawa, K. Nishiyama, T. Hashimoto, S. Sekine, et al. 2020. Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3. Gut 69 (2): 243\u2013251.","journal-title":"Gut"},{"issue":"7","key":"2002_CR74","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/jnen\/nlaa038","volume":"79","author":"G Gauchotte","year":"2020","unstructured":"Gauchotte, G., M. Peyre, C. Pouget, D. Cazals-Hatem, M. Polivka, F. Rech, P. Varlet, H. Loiseau, S. Lacomme, K. Mokhtari, et al. 2020. Prognostic value of histopathological features and loss of H3K27me3 immunolabeling in anaplastic meningioma: A multicenter retrospective study. Journal of Neuropathology and Experimental Neurology 79 (7): 754\u2013762.","journal-title":"Journal of neuropathology and experimental neurology"},{"issue":"1","key":"2002_CR75","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41467-019-09140-x","volume":"10","author":"AS Harutyunyan","year":"2019","unstructured":"Harutyunyan, A.S., B. Krug, H. Chen, S. Papillon-Cavanagh, M. Zeinieh, N. De Jay, S. Deshmukh, C.C.L. Chen, J. Belle, L.G. Mikael, et al. 2019. H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2\/me3 and is essential for glioma tumorigenesis. Nature Communications 10 (1): 1262.","journal-title":"Nature Communications"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02002-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T09:05:57Z","timestamp":1731056757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02002-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2002"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02002-9","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"assertion":[{"value":"16 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences (no. 2022\u2013108-KY). All subjects provided written informed consent prior to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}